After reviewing new evidence since its previous recommendation, the United States Preventive Services Task Force (USPSTF) is still advising against routine screening for ovarian cancer. The recommendation is very much in keeping with its recent recommendations for breast cancer screening and PSA screenings for prostate cancer.
After reviewing new evidence since its previous recommendation, the United States Preventive Services Task Force (USPSTF) is still advising against routine screening for ovarian cancer. The recommendation is very much in keeping with its recent recommendations for breast cancer screening and PSA screenings for prostate cancer.
The Task Force found that annual screening in women who do not possess known risk factors for ovarian cancer (certain genetic mutations, Lynch syndrome, a family history of the disease), does not reduce the number of deaths from the disease and can actually lead to more harm than benefit.
